| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Across the last three months, Johnson & Johnson's insiders have reduced their positions by a net 236,286 shares worth roughly $62.0M.
JNJ sits in the Pharmaceuticals industry within the Health Care sector, so this activity is best read against the sector's broader insider trend.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 276.0K | $72.03M | - | |
| VP | 194.5K | $51.21M | - | |
| VP | 114.3K | $27.56M | - | |
| VP | 25.7K | $6.24M | - | |
| VP | 25.4K | $3.85M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Feb 17, 2026 | Reed John C | EVP, Innovative Medicine, R&D | Sale+OE | 53,931 | $243.00 | $13,105,233.00 | -83.5% | -5.9% | - | |
| Feb 17, 2026 | Wolk Joseph J | Executive VP, CFO | Sale+OE | 89,654 | $242.80 | $21,767,826.99 | -86.5% | -5.9% | - | |
| Feb 17, 2026 | Swanson James D. | EVP, CIO | Sale+OE | 62,080 | $243.39 | $15,109,758.99 | -70.7% | -5.9% | - | |
| Feb 17, 2026 | Broadhurst Vanessa | EVP, Global Corp Affairs | Sale+OE | 6,197 | $243.39 | $1,508,287.83 | -21.2% | -5.9% | - | |
| Jan 26, 2026 | Duato Joaquin | CEO and Chairman of the Board | Sell | 100,000 | $221.23 | $22,122,893.44 | -76.4% | +1.7% | - | |
| Nov 26, 2025 | Morikis John G64 | Director | Buy | 1,250 | $206.15 | $257,687.50 | +208.9% | +18.7% | - | |
| Oct 17, 2025 | Reed John C | EVP, Innovative Medicine, R&D | Sale+OE | 21,721 | $192.71 | $4,185,793.09 | -67.1% | +13.6% | +32.3% | |
| Sep 4, 2025 | Taubert Jennifer L60 | EVP, Wwc. Innovative Medicine | Sale+OE | 56,471 | $177.81 | $10,040,882.63 | -24.1% | +14.9% | +54.0% | |
| Aug 22, 2025 | Duato Joaquin | CEO and Chairman of the Board | Sale+OE | 125,824 | $179.21 | $22,548,654.81 | -31.3% | +13.3% | +50.7% | |
| Aug 15, 2025 | Wolk Joseph J | Executive VP, CFO | Sale+OE | 16,820 | $176.91 | $2,975,570.69 | -54.6% | +10.5% | +47.4% |